Related Experiment Video
Updated: May 4, 2026

07:37
Translational Orthotopic Models of Glioblastoma Multiforme
Published on: February 17, 2023
3.7K
Primary gliosarcoma of the brain: radiologic and histopathologic features
Alfredo E Romero-Rojas1, Julio A Diaz-Perez, Lina M Ariza-Serrano
1National Institute of Cancer; Bogotá, Colombia - jdiazperez@ucsd.edu - patologia@udes.edu.co.
The Neuroradiology Journal
|December 21, 2013
Summary
This study details the radiologic and histopathologic features of primary gliosarcoma, a rare brain tumor. Early diagnosis through understanding these features is crucial for improving patient outcomes.
Area of Science:
- Neuro-oncology
- Radiology
- Pathology
Background:
- Gliosarcoma is a rare central nervous system (CNS) neoplasm characterized by biphasic glial and non-glial malignant components.
- Patients often present with rapid clinical deterioration, with common symptoms including headache and seizures.
Purpose of the Study:
- To describe the radiologic and histopathologic features of primary gliosarcoma.
- To emphasize the importance of early diagnosis for improved patient outcomes.
Main Methods:
- Analysis of radiologic (CT, MRI, MR spectroscopy) and histopathologic features in five primary gliosarcoma cases.
- Evaluation of glial and sarcomatous components, including Ki67 and p53 expression, and documentation of dedifferentiation types.
Main Results:
- Tumors were large, predominantly affecting the temporal lobe, with common imaging findings including annular contrast enhancement, peripheral edema, and central calcification.
- Histopathology revealed malignant astrocytes and pleomorphic spindle cells with high Ki67 and p53 positivity, showing various dedifferentiation patterns.
- Median overall survival was ten months following radiotherapy/chemotherapy.
Conclusions:
- Radiologic and histopathologic characterization of primary gliosarcoma is essential for timely diagnosis.
- Understanding these features can potentially lead to better therapeutic strategies and improved patient survival in this rare CNS neoplasm.

